Association between Body Mass Index and Response to Duloxetine for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in SWOG S1202

BACKGROUND: Aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) negatively impact adherence and persistence with therapy. In SWOG S1202, patients with AIMSS treated with duloxetine, a serotonin norepinephrine reuptake inhibitor, reported improvement in pain by 12 weeks compared to p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Henry, N. Lynn, Unger, Joseph M., Till, Cathee, Schott, Anne F., Crew, Katherine D., Lew, Danika L., Fisch, Michael J., Moinpour, Carol M., Wade, James L., Hershman, Dawn L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6675412/
https://ncbi.nlm.nih.gov/pubmed/30861098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados